Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
arborpharma.com

See what CB Insights has to offer

Total Raised

$34.8M

Investors Count

5

Deal Terms

1

Arbor Pharmaceuticals Funding, Arbor Pharmaceuticals Valuation & Arbor Pharmaceuticals Revenue

4 Fundings

Arbor Pharmaceuticals's latest funding round was a Acquired for on August 24, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/24/2021

Acquired

1

12/5/2014

Private Equity

10

11/12/2010

Series B

$99M

0

11/12/2010

Debt

$99M

0

Date

8/24/2021

12/5/2014

11/12/2010

11/12/2010

Round

Acquired

Private Equity

Series B

Debt

Amount

$99M

$99M

Investors

Valuation

Revenue

Sources

1

10

0

0

Arbor Pharmaceuticals Deal Terms

1 Deal Term

Arbor Pharmaceuticals's deal structure is available for 1 funding round, including their Series B from November 12, 2010.

Round

Series B

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

$99M

Conversion Price

Anti Dilution

$99M

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Arbor Pharmaceuticals Investors

5 Investors

Arbor Pharmaceuticals has 5 investors. Azurity Pharmaceuticals invested in Arbor Pharmaceuticals's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/24/2021

8/24/2021

1
Acquired

Corporation

Massachusetts

00/00/0000

00/00/0000

KKR

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

Signet Healthcare Partners

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

JW Asset Management

Subscribe to see more

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

ARCH Healthcare Fund

Subscribe to see more

First funding

8/24/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/24/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

KKR

Signet Healthcare Partners

JW Asset Management

ARCH Healthcare Fund

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Private Equity

Private Equity

Asset/Investment Management

Location

Massachusetts

New York

New York

New York

Arbor Pharmaceuticals Acquisitions

2 Acquisitions

Arbor Pharmaceuticals acquired 2 companies. Their latest acquisition was XenoPort on May 23, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/23/2016

Series D

$99M

$145.57M

Acquired

1

1/1/2009

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

5/23/2016

1/1/2009

Investment Stage

Series D

Other Venture Capital

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$145.57M

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.